CCL5 and chronic kidney disease: RS supplementation reduces platelet-derived growth factor (PDGF), regulated upon activation, normal T cell expressed and secreted (RANTES) [also known as CCL5], and interferon-inducible protein 10 (IP-10) [also known as CXCL10] in CKD (56).